Private Advisor Group’s Editas Medicine EDIT Stock Holding History

Private Advisor Group’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-6,296	Closed	-$259K	–	2167
2021 Q3	$259K	Sell	6,296 -5,187	-45%	-$284K	﹤0.01%	1767
2021 Q2	$650K	Sell	11,483 -970	-8%	-$35.8K	0.01%	1268
2021 Q1	$523K	Buy	12,453 +4,692	+60%	+$267K	0.01%	1276
2020 Q4	$545K	Buy	+7,761	New	+$319K	0.01%	1178
2020 Q3	–	Sell	-4,389	Closed	-$130K	–	2055
2020 Q2	$130K	Buy	+4,389	New	+$115K	﹤0.01%	1559

Other funds holding EDIT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Private Advisor Group's EDIT Position: Q4 2021 in Review

Private Advisor Group sold out of Editas Medicine (EDIT) in Q4 2021, closing a stake of 6,296 shares — an estimated $259K sold.

Private Advisor Group first reported a position in EDIT in Q2 2020 and held it in 5 quarters. The position peaked at $650K in Q2 2021. 305 funds tracked by Wall St. Rank hold EDIT as of Q4 2021.

Private Advisor Group reported no remaining Editas Medicine position as of Q4 2021 after selling out during the quarter.
Private Advisor Group sold 6,296 Editas Medicine shares in Q4 2021, an estimated $259K.
Private Advisor Group first reported a position in Editas Medicine in Q2 2020 and held it in 5 quarters.
Private Advisor Group's Editas Medicine position peaked at $650K in Q2 2021.
305 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2021.

Based on Private Advisor Group's 13F filing for Q4 2021, filed 10 Feb 2022.